Peter Kamenický

27PUBLICATIONS
127CO-AUTHORS
Genome structure and regulationInfant and child healthPacific Peoples and disabilityToxicology (incl. clinical toxicology)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jun 17, 2026
The renin-angiotensin system is activated by short-term, but repressed by long-term growth hormone excess.

|May 20, 2026
Continuous subcutaneous recombinant PTH(1-34) infusion improves serum calcium and phosphate homeostasis in children with autosomal dominant hypocalcemia type 1 refractory to standard-of-care treatment.

|Apr 27, 2026
Health-related quality of life in French adults with X-linked hypophosphatemia: real-world data from the International XLH Registry.

|Apr 15, 2026
Risk of bone overstimulation in long-term PTH(1-34) therapy for hypoparathyroidism.

|Dec 24, 2025
Continuous subcutaneous administration of teriparatide as a therapeutic option in chronic hypoparathyroidism: retrospective study in three tertiary care centers of the epi-hypo study.

Amina Attia, Mathilde Brière, Peter Kamenicky

|Nov 21, 2025
RNF216 Variants Found in Patients With Dementia, Hypogonadotropic Hypogonadism, and Severe Ataxia Deregulate Autophagy.

Jacques Young, Inès Abdennebi, Marion Le Saëc

Pageof 5

Frequent Collaborators

6 joint publications

Peter Wolf

6 joint publications

Philippe Chanson

6 joint publications

Karine Briot

5 joint publications

Luigi Maione